Current Affairs - July 2020
Which pharma company seeks permission from DGCI for 'phase 2&3' clinical trials of Oxford vaccine under brand name "Covishield" in India?

Bharat Biotech
Indian Drugs and Pharmaceuticals Limited
Serum Institute of India
Indian Immunologicals

ANSWER DOWNLOAD EXAMIANS APP